Symptom Response in PKU Patients
Sapropterin dihydrochloride (Kuvan), approved for phenylketonuria (PKU), reduces blood phenylalanine (Phe) levels in responsive patients—typically 20-30% of those tested—when taken consistently at 10-20 mg/kg/day. Consistent treatment over 6-12 weeks lowers mean Phe by 30-50% in responders, from baseline >600 μmol/L to 300-500 μmol/L range.[1][2]
How Responsiveness Is Measured
Clinicians test response with a 30 mg/kg single-dose challenge or 8-week trial. Responders show ≥30% Phe drop. Long-term data from open-label studies (up to 6+ years) confirm sustained Phe control in 75-90% of initial responders, enabling dietary Phe relaxation by 25-50% without symptom rebound.[1][3]
Effects on Neurological Symptoms
In early-treated PKU patients (classic or mild hyperphenylalaninemia), consistent sapropterin improves executive function, attention, and processing speed. IQ stabilizes or rises 5-10 points in children after 1-2 years; adults report better mood and reduced fatigue. Non-responders see no change.[2][4]
Impact on Other Symptoms
- Dermatological: Eczema and skin rashes decrease in 40-60% of cases as Phe drops.
- Behavioral: Irritability and anxiety lessen in responsive adolescents/adults.
- Growth: Weight gain improves in underweight children.[3][5]
Time to See Changes
Phe reduction starts within 4 weeks; symptom relief (e.g., cognitive) emerges at 6-12 months. Daily adherence is key—missing doses raises Phe within days.[1][2]
Who Responds Best
BH4 loading test identifies candidates: infants under 4 years respond 50-70%; adults 20-40%. Genetics (PAH variants like R408W partial responders) predict outcomes.[4][6]
Limitations and Non-Responders
50-80% do not respond; symptoms persist or worsen if Phe rises. No benefit in severe PAH mutations. Side effects like headache (10-15%) or rhinitis rarely halt treatment.[2][5]
Sources
[1]: FDA Label for Kuvan
[2]: BioMarin Clinical Data
[3]: NEJM PKU Trial (2007)
[4]: J Inherit Metab Dis Review (2019)
[5]: DrugPatentWatch.com - Sapropterin
[6]: Genetics Home Reference - PKU